Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC

Clinical trial NCT07572864 · RECRUITING

Trial details

NCT number: NCT07572864
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2026-06-29
Primary completion: 2027-05-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.